L22 - Hypersensitivity type 3 and 4 Flashcards
(45 cards)
what is an immune complex
formed by binding of antibody to soluble antigen
difference in what happens to large or small immune complexes
large:
rapidly cleared by macrophages easily
small:
when there is excess soluble antigen present –> if not cleared it can be depoisited in tissues
= T3 hypersensitivity reactions
describe the clearance of immune complexes in healthy individuals
- Antibody binds to soluble antigen forming IC
- C1 complex binds to Fc receptors on the bound antibodies actiovating classical copmplement cascade
- C3 converase produced and C3b molecules ‘depoisited’ on surface of immune complex
- Complement receptors (CR1) on blood cells bind to C3b and C5b molecules
- transported to liver and spleen where phagocytes with Fc receptors bind to iIC via antibdoes Fc region
–> IC degraded and blood cells/ethryocytes are released/stripped of bound IC
dfifference between T2 and T3 hypersensitivity reactions
both use same isotype of antibodies - IgG - with Fc receptors
T2 –> antibody on cell/EC<
T3 –> antbody on soluble antigen = Immune complex
which antibody are T3 HS reactions primarily mediated by
IgG
how could you get damage from an envirnmental antigen from inhalation - T3
- Local immune complexes form in alveoli of lungs
- accumalation of fluid,protein and cells in the avelolar wall –> slows down gas exchange
- inflammation and fibrosus cause permanent damage
describe how Immune Complexes Interact with Fc Receptors on Basophils and Platelets
Antigen-antibody clusters bind to Fc receptors (FcγR) on basophils and platelets
= active basophils produce histamine
= platelet activation induces release of pro-inflammatory mediators like serotonin and platelet factor 4.
Mediators initiate local inflammation and contribute to vascular changes.
define inflammation
body’s protective response to infection, injury, or harmful stimuli
- Vascular changes – increased blood flow and permeability
- Immune cell recruitment – especially neutrophils, macrophages, and lymphocytes.
- Chemical mediators – cytokines, chemokines, prostaglandins, histamine, and complement proteins.
how do Immune complexes interact with complement to trigger inflammation
Activate the classical complement pathway -resulting in cleavage of:
C3 → C3a + C3b
C5 → C5a + c5b
= ‘a’s are anaphylotoxins bind to C3aR, C5aR receptors on mast and basiphils = degranulation –> histamine release
= ‘b’s are bound by CR receptors
explain how immune complexes affect macrophaes to trigger inflammation
ICs are phagocytosed –> intracellular signalling –> macrophages produce IL-1 and TNF-a
= inflmmatory cytokines
name the inflammatory cytokines produced by activated macrophages due to ingestion of immune complexes
Il-1 and TNF-a
how do IL-1 and TNF-a cause fever
Act on the hypothalamus to raise the body temperature set point.
= Promote production of prostaglandin E2 (PGE2) → fever –> helps inhibit pathogen replication.
what do ‘Histamine, serotonin, C3a, C5a, IL-1, and TNF-α’ all contribute to in inflammatory response
vascular permeability
= endothelialcells retract exposingf basement membrane –> ICs can get lodged here
= can trigger locxal complement acytivation causing tissue damage
describe the steps involved in formation of microthrombi from Immune complexes
- platelets express CD32 receptor which binds to IgG of ICs
- platelets also bind to exposed collagen of basement membrane via GPVI
= actiavtes platelets by combination of both pathways
- Platelets link to each other through Fibrinogen bridges = microthromibi
= limited space means that build up limits blood flow
how does complement reduce formation of insoluble ICs on tissues
complement components increase solubility of immune complexes
= increases their hydrophilicity and reduces their tendency to aggregate
= CR receptors on blood cells also allow removal from circulation to spleen/liver
defiencies in complement can cause problems
why is MAC NOT formed in immune complexes
no membrane for C5b to anchor to properly/insert into
= prevents rest of MAC assembly
how do immune complexes cause a cycle of complement activation in SLE patients
immune complex form
complement activation
tissue damage
antigen release from cells
–> more ICs form
describe the dual role of patuents with systemic lupus erthyematous - SLE
patients have autoantibdoies against DNA,cytoplasmic proteins of their own cells
antibodies bind following apoptosus to form immune complexes
- complement binding to ICs improves solubility and helps clearance by CR1 and ethryocyteds
- overloadfed sysrem causes deposition in cappilary beds activating complement in tissues –> more damage
what is ATG
Anti-thymocyte globulin
= polyclonal antibody produced in horse or rabbit against human T cells
used as an immunosuppressant to reduce chance of rejection in graft/transplant
what is the probelm with using ATg as an immunosuppressant in transplants
derived from non-human source
= can be recognised as forign and immune reponse created = serum sickness
what is serum sickness
exposure to forign protein caysing antigen:antibody immune complexes to form ajnd be depoisited thoughout body
= systemic Type 3 hypersensitivity
how can we reduce chance of serum sickness when using things like ATG as an immunosuppressant
engineering monoclonal antibodies ro reduce the amount of non-human protein used
= orthoclones have complimnetarity regions frommouse and the REST of protein is human
= less to be recognised as forign
whats another word for T4 hypersensitivity
delayed-type
= atleast 12 hours to manifest
what type of peiople can T4 HS take place in and can not take place
can –> antibody-defienct humans
can’t –> AIDs patients
= T cells needed